Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re Cassava Sciences, Inc. Securities Litigation
Case Number:
1:21-cv-00751
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Ahmad Zavitsanos
- Baker & Hostetler
- Berger Montague
- Bilek Law Firm
- Block & Leviton
- Burns Charest
- Condon Tobin
- Faruqi & Faruqi
- Fears Law
- Federman & Sherwood
- Forester Haynie
- George Brothers
- Gibson Dunn
- Glancy Prongay
- Johnson Fistel
- Kahn Swick
- Morgan & Morgan PA
- Orrick Herrington
- Parsons McEntire
- Pomerantz LLP
- Robbins Geller
- Steckler Wayne
- Steptoe LLP
-
August 13, 2025
Cassava Investors Get Class Certified In Alzheimer's Drug Suit
Investors accusing Cassava Sciences Inc. of inflating its stock price with manipulated research data of its Alzheimer's drug can proceed with their claims as a class, with the court finding the suit's named plaintiffs are adequate representatives despite Cassava's claims they were only "out to make a quick buck."
-
January 20, 2022
Investors Say Biotech Co. Altered Alzheimer Drug Data
Texas-based biotechnology company Cassava Sciences Inc. has oversold to the public and the U.S. Food and Drug Administration the efficacy of its two products that can allegedly detect signs of Alzheimer's disease and treat it, according to a slew of class actions filed in the Lone Star State.